Safety and efficacy of combined antiplatelet and low-dose rivaroxaban in patients with chronic limb threatening ischaemia in Singapore.
10.47102/annals-acadmedsg.202282
- Author:
Claire Alexandra CHEW
1
;
Julian Chi Leung WONG
;
Charyl Jia Qi YAP
;
Shereen Xue Yun SOON
;
Tjun Yip TANG
Author Information
1. Department of Surgery, National University Hospital, Singapore.
- Publication Type:Journal Article
- MeSH:
Chronic Limb-Threatening Ischemia;
Factor Xa Inhibitors/adverse effects*;
Humans;
Platelet Aggregation Inhibitors/adverse effects*;
Rivaroxaban/adverse effects*;
Singapore;
Treatment Outcome
- From:Annals of the Academy of Medicine, Singapore
2022;51(9):580-582
- CountrySingapore
- Language:English
